MicroRNA Expression Profile Changes in the Leukocytes of Parkinson's Disease Patients
N S Ardashirova1, N Yu Abramycheva1, E Yu Fedotova1
1Research Center of Neurology, Moscow, 125367 Russia.
Abstract:
Parkinson's disease (PD) is one of the most common movement disorders. It is primarily diagnosed clinically. A correct diagnosis of PD in its early stages is important for the development of a pathogenic treatment, which necessitates a search for potential biomarkers of the disease. We evaluated the diagnostic value of several microRNAs and their relationship with the clinical characteristics of PD. The study included 70 PD patients and 40 healthy volunteers. We analyzed the expression of 15 microRNAs in blood leukocytes, which were selected based on literature data and modern concepts of molecular PD pathogenesis. All patients were evaluated using the Hoehn and Yahr scale, UPDRS, NMSQ, and PDQ-39. The data analysis revealed a statistically significant increase in the expression of miR-7-5p, miR-29c-3p, and miR-185-5p and a statistically significant decrease in the expression of miR-29a-3p and miR-30c-1-5p in leukocytes in PD. However, the altered microRNA profile was shown to have a moderate diagnostic value for PD diagnosis. MicroRNA expression changes were associated with the motor and non-motor phenotypic features of PD and administration of anti-Parkinson's drugs. Also, a relationship between some of the microRNAs studied and the duration and severity of PD was found, which may potentially be used to monitor disease progression.
Insights
Researchers identified specific microRNA (miRNA) expression changes in Parkinson
Area of Science:
- Neuroscience
- Molecular Biology
- Genetics
Background:
- Parkinson's disease (PD) is a common neurodegenerative movement disorder, primarily diagnosed clinically.
- Early diagnosis of PD is crucial for developing effective treatments, necessitating the identification of reliable biomarkers.
- MicroRNAs (miRNAs) are under investigation as potential molecular markers for various diseases, including PD.
Purpose of the Study:
- To evaluate the diagnostic value of specific microRNAs in Parkinson's disease.
- To investigate the relationship between altered microRNA expression and the clinical characteristics of PD.
- To explore the potential of miRNAs as biomarkers for PD diagnosis and progression monitoring.
Main Methods:
- Analysis of 15 selected microRNAs in blood leukocytes from 70 PD patients and 40 healthy controls.
- Clinical assessment of PD patients using Hoehn and Yahr scale, UPDRS, NMSQ, and PDQ-39.
- Statistical analysis to compare miRNA expression levels and correlate them with clinical features.
Main Results:
- Statistically significant alterations in the expression of five miRNAs (miR-7-5p, miR-29c-3p, miR-185-5p, miR-29a-3p, miR-30c-1-5p) were observed in PD patients.
- The identified microRNA profile demonstrated moderate diagnostic value for Parkinson's disease.
- Changes in miRNA expression correlated with motor and non-motor symptoms, medication, disease duration, and severity.
Conclusions:
- Specific microRNA expression patterns in leukocytes may serve as potential biomarkers for Parkinson's disease.
- These microRNA alterations are associated with the clinical phenotype and progression of PD.
- Further research could validate these miRNAs for early diagnosis and monitoring of Parkinson's disease.
Related Concept Videos
01:37Neural Regulation
01:15Parkinson's Disease: Overview
01:22MicroRNAs
01:24Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...